Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
SIMPLE Chemotherapy for NK Lymphoma/Leukaemia
- Status
- UNKNOWN
- Phase
- PHASE3
PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
The Efficacy of Salvage BGD With autoSCT Consolidation in Advanced Classical HL Patients Not Responding to ABVD
- Status
- COMPLETED
- Phase
- PHASE2
MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Acelarin First Line Randomised Pancreatic Study
- Status
- SUSPENDED
- Phase
- PHASE2/PHASE3
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Chidamide Combined With Clad/Gem/Bu With AutoSCT in High Risk Hodgkin & Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Oral Azacitidine Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory AITL
- Status
- COMPLETED
- Phase
- PHASE3
Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
Phase II Umbrella Study Directed by Next Generation Sequencing
- Status
- UNKNOWN
- Phase
- PHASE2
Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
QUILT-3.088: NANT Pancreatic Cancer Vaccine
- Status
- WITHDRAWN
- Phase
- PHASE2
A Double Blind, Placebo Controlled, Randomized Phase II Study Evaluating Gemcitabine With or Without Ramucirumab , for II Line Treatment MPM
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine, Cisplatin, Plus Nivolumab in Patients With Muscle-invasive Bladder Cancer With Selective Bladder Sparing
- Status
- COMPLETED
- Phase
- PHASE2